Novartis splits drugs business into two
David Epstein, Division Head and Chief Executive, Novartis Pharmaceuticals to leave the company
Novartis is splitting its…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Novartis
Novartis’ Afinitor reduces seizures in patients with tuberous sclerosis complex
Results presented at American Academy of Neurology will be discussed with health authorities for potential worldwide regulatory…
Sun Pharma enters Japanese prescription market
Acquires 14 prescription brands
Sun Pharma has acquired 14 established prescription brands from Novartis in Japan. According to…
Aurobindo Pharma receives US FDA approval for rivastigmine tartrate capsules
The product is expected to be launched in Q1 FY16-17
GlaxoSmithKline posts loss as it integrates new businesses
Drug makers like GSK have been trying to focus on strengths amid competition from generic drug makers
British-based drug maker…
Novartis’ two major trials shows significant efficacy of Cosentyx in ankylosing spondylitis…
The study enrolled anti-TNF naïve patients and patients who had previously failed anti-TNF therapy, with clinical benefits…
Regulatory submission for Sandoz’ proposed biosimilar pegfilgrastim accepted by FDA
Proposed biosimilar pegfilgrastim filing is the second of ten regulatory filings planned over the next three years
Sandoz, a…
Kenya launches ‘Novartis Access’
Agreements signed with Kenyan government and NGOs include programmes to distribute medicines, raise disease awareness and…
Novartis launches access programme for 15 medicines
Novartis Access to be launched first in Kenya, Ethiopia and Vietnam
Novartis has launched Novartis Access, a portfolio of 15…
Sandoz launches Zarxio, the first biosimilar in US
Sandoz One Source, a patient services centre, was also launched
Zarxio by Sandoz, a Novartis company, is now available in the US.…